1067637-96-0

Basic information

• Product Name: N-8-(5-chloro-2-methoxyphenyl)-5,6-dihydro-4H-cyclohepta[1,2-d:3,4-d′]bis(thiazole)-2,8-diamine
• Synonyms: N-8-(5-chloro-2-methoxyphenyl)-5,6-dihydro-4H-cyclohepta[1,2-d:3,4-d′]bis(thiazole)-2,8-diamine
• CAS NO: 1067637-96-0
• Molecular Weight: 378.906
• Mol File: 1067637-96-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-8-(5-chloro-2-methoxyphenyl)-5,6-dihydro-4H-cyclohepta[1,2-d:3,4-d′]bis(thiazole)-2,8-diamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-8-(5-chloro-2-methoxyphenyl)-5,6-dihydro-4H-cyclohepta[1,2-d:3,4-d′]bis(thiazole)-2,8-diamine(1067637-96-0)
• EPA Substance Registry System: N-8-(5-chloro-2-methoxyphenyl)-5,6-dihydro-4H-cyclohepta[1,2-d:3,4-d′]bis(thiazole)-2,8-diamine(1067637-96-0)

Safety Data

• Hazardous Substances Data: 1067637-96-0(Hazardous Substances Data)

Upstream product

• 19980-43-9 1-(trimethylsilyloxy)cyclopentene 
• 66324-01-4 1-trimethylsilyloxy-7,7-dichlorobicyclo[3.2.0]heptan-6-one 
• 883195-38-8 2-amino-4,5,6,7-tetrahydro-8H-cyclohepta[d]thiazol-8-one 
• 1017589-91-1 2-bromocycloheptane-1,3-dione 
• 1194-18-9 cycloheptane-1,3-dione 

Downstream Products

• 1067637-97-1 N-(8-((5-chloro-2-methoxyphenyl)amino)-5,6-dihydro-4H-cyclohepta[1,2-d:3,4-d′]bis(thiazole)-2-yl)pivalamide 

Relevant articles and documents

Constrained bithiazoles: Small molecule correctors of defective δf508-CFTR protein trafficking

Conformationally constrained bithiazoles were previously found to have improved efficacy over nonconstrained bithiazoles for correction of defective cellular processing of the δF508 mutant cystic fibrosis transmembrane conductance regulator (CFTR) protein. In this study, two sets of constrained bithiazoles were designed, synthesized, and tested in vitro using δF508-CFTR expressing epithelial cells. The SAR data demonstrated that modulating the constraining ring size between 7-versus 8-membered in these constrained bithiazole correctors did not significantly enhance their potency (IC50), but strongly affected maximum efficacy (Vmax), with constrained bithiazoles 9e and 10c increasing Vmax by 1.5-fold compared to benchmark bithiazole corr4a. The data suggest that the 7-and 8-membered constrained ring bithiazoles are similar in their ability to accommodate the requisite geometric constraints during protein binding.